Natco Pharma Archives - Express Pharma

US tariffs, IP issues threaten patient access

Indian biotech firm develops first indigenous bi-specific 3rd generation CAR T cells for cancer treatment

NATCO Canada announces $ 8 mn investment in eGenesis

Fortifying Brand India Pharma

Pee Safe partially closes Series B round with $3 mn from Natco Pharma, Rainmatter Health

NATCO announces ANDA filing for generic olaparib tablets in US

Delhi HC rules in favour of Natco in patent infringement case

NATCO gets ANDA approval for Cabazitaxel Intravenous Solution

Natco Pharma plans to launch Molnupiravir capsules this week

Natco Pharma launches novel fixed-dose combination drug for colorectal, gastric cancer